Ovid Therapeutics (OVID) Stock Chart & Stock Price History $0.82 -0.04 (-4.90%) As of 03:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Ovid Therapeutics Stock Price Performance The Ovid Therapeutics (OVID) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 19.21%, with a year-to-date return of -12.61%. In the past month, the stock has increased 105.59%, reflecting recent market activity. As of the latest close, Ovid Therapeutics traded at $0.86 with a market cap of $61.01 million and volume of 9.25 million shares. Five years ago, the stock traded at $7.50, representing a 89.12% decrease over that period. At the time, it had a market cap of $392.01 million and a volume of 581,760 shares. Receive OVID Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+58.48%1 Month Performance+105.59%3 Month Performance+176.70%Year-To-Date Performance-12.61%1 Year Performance-19.21%5 Year Performance-89.12% OVID Stock Chart for Thursday, August, 14, 2025 OVID Chart by TradingView Ovid Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/13/2025$0.55$0.86+56.86%$0.87$0.559.25 million shs$61.01 million08/12/2025$0.56$0.55-1.57%$0.59$0.53389,585 shs$38.90 million08/11/2025$0.51$0.56+7.92%$0.56$0.52688,570 shs$39.52 million08/08/2025$0.51$0.51+0.66%$0.54$0.50381,631 shs$36.62 million08/07/2025$0.51$0.51+0.25%$0.52$0.50429,701 shs$36.37 million08/06/2025$0.50$0.51+2.80%$0.51$0.48337,146 shs$36.28 million08/05/2025$0.50$0.50-0.04%$0.51$0.48603,099 shs$35.29 million08/04/2025$0.50$0.50-0.70%$0.51$0.48574,117 shs$35.31 million08/01/2025$0.50$0.50$0.51$0.48535,545 shs$35.56 million07/31/2025$0.50$0.50$0.52$0.48800,863 shs$35.56 million Get the Latest News and Ratings for OVID and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/30/2025$0.54$0.50-7.46%$0.55$0.491.16 million shs$35.56 million07/29/2025$0.53$0.54+2.43%$0.58$0.521.09 million shs$38.42 million07/28/2025$0.62$0.53-14.71%$0.63$0.521.57 million shs$37.51 million07/25/2025$0.69$0.62-10.75%$0.70$0.611.08 million shs$43.98 million07/24/2025$0.70$0.69-1.00%$0.73$0.602.14 million shs$49.28 million07/23/2025$0.67$0.70+4.65%$0.73$0.681.94 million shs$49.78 million07/22/2025$0.61$0.67+10.49%$0.67$0.591.78 million shs$47.57 million07/21/2025$0.55$0.61+10.07%$0.63$0.562.66 million shs$43.05 million07/18/2025$0.48$0.55+14.75%$0.57$0.483.44 million shs$39.11 million07/17/2025$0.39$0.48+22.90%$0.61$0.4124.44 million shs$34.08 million07/16/2025$0.37$0.39+5.98%$0.40$0.36495,126 shs$27.73 million07/15/2025$0.40$0.37-7.28%$0.41$0.36805,184 shs$26.17 million07/14/2025$0.41$0.40-2.00%$0.41$0.39443,469 shs$28.22 million Related Companies NVCT Stock Price Chart GNLX Stock Price Chart CGEN Stock Price Chart KRRO Stock Price Chart SPRO Stock Price Chart BHST Stock Price Chart FATE Stock Price Chart MCRB Stock Price Chart IMRX Stock Price Chart PLX Stock Price Chart Receive OVID Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OVID) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ovid Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Ovid Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access